Skip to main content

Master of Public Health

Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.

AUTHORS

Melekhin VV , Shepherd BE , Stinnette SE , Rebeiro PF , Barkanic G , Raffanti SP , Sterling TR , . PloS one. 2009 1 1; 4(9). e6961

ABSTRACT

Pregnancy has been associated with a decreased risk of HIV disease progression in the highly active antiretroviral therapy (HAART) era. The effect of timing of HAART initiation relative to pregnancy on maternal virologic, immunologic and clinical outcomes has not been assessed.

Pregnancy has been associated with a decreased risk of HIV disease progression in the highly active antiretroviral therapy (HAART) era. The effect of timing of HAART initiation relative to pregnancy on maternal virologic, immunologic and clinical outcomes has not been assessed.

Tags: